Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome

Blood

Volumn 92, Issue 5, 1998, Pages 1735-1742

  Reiter, Andreas ^b   Sohal, Jastinder ^b   Kulkarni, Shashikant ^b   Chase, Andrew ^b   Macdonald, Donald H C ^b   Aguiar, Ricardo C T ^b   Gonçalves, Cristina ^b   Hernandez, Jesus M ^b   Jennings, Barbara A ^b   Goldman, John M ^b   Cross, Nicholas C P ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR;

ARTICLE; CHROMOSOME 13Q; CHROMOSOME 8P; CHROMOSOME TRANSLOCATION 13; CHROMOSOME TRANSLOCATION 8; DNA SEQUENCE; ENZYME ACTIVATION; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; YEAST ARTIFICIAL CHROMOSOME;

EID: 0032170974     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.5.1735     Document Type: Article

References (39)

1. Asimakopoulos FA, Green AR: Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders. Br J Haematol 95:219, 1996
2. Macdonald D, Aguiar RCT, Mason PJ, Goldman JM, Cross NCP: A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: Areview. Leukemia9:1628, 1995
3. Inhorn RC, Aster JC, Roach SA, Slapak CA, Soiffer R, Tantravahi R, Stone RM: A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): Description of a distinctive clinicopathologic entity. Blood 85:1881, 1995
4. Macdonald D, Sheerin SM, Cross NCP, Spencer A, Goldman JM: An atypical myeloproliferative disorder with t(8;13) (p11;q12): A third case. Br J Haematol 86:879, 1994
5. Leslie J, Barker T, Glancy M, Jennings B, Pearson J: t(8;13) (p11;q12) Translocation in a myeloproliferative disorder associated with a T-cell non-Hodgkin lymphoma. Br J Haematol 86:876, 1994
6. Aguiar RCT, Chase A, Coulthard S, Macdonald DHC, Carapeti M, Reiter A, Sohal J, Lennard A, Goldman JM, Cross NCP: Abnormalities of chromosome band 8p11 in leukemia: Two clinical syndromes can be distinguished on the basis of MOZ involvement. Blood 90:3130, 1997
7. Guilford P, Dode C, Crozet F, Blanchard S, Chaib H, Levilliers J, Levi Acobas F, Weil D, Weissenbach J, Cohen D, Le Paslier D, Kaplan J-C, Petit C: A YAC contig and an EST map in the pericentromeric region of chromosome 13 surrounding the loci for neurosensory nonsyndromic deafness (DFNB1 and DFNA3) and limb-girdle muscular dystrophy type 2C (LGMD2C). Genomics 29:163, 1995
8. Zhang JG, Goldman JM, Cross NCP: Characterization of genomic BCR-ABL breakpoints in chronic myeloid leukaemia by PCR. Br J Haematol 90:138, 1995
9. Burn TC, Connors TD, Klinger KW, Landes GM: Increased exon-trapping efficiency through modifications to the pSPL3 splicing vector. Gene 161:183, 1995
10. Frohman MA: Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: Thermal RACE. Methods Enzymol 218:340, 1993
11. Cross NCP, Melo JV, Feng L, Goldman JM: An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia 8:186, 1994
12. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Kazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J: A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152, 1996
13. Kempski H, MacDonald D, Michalski AJ, Roberts T, Goldman JM, Cross NCP, Cowell JK: Localization of the 8;13 translocation breakpoint associated with myeloproliferative disease to a 1.5 Mbp region of chromosome 13. Genes Chromosomes Cancer 12:283, 1995
14. Wood S, Schertzer M, Yaremko ML: Sequence identity locates CEBPD and FGFR1 to mapped human loci within proximal 8p. Cytogenet Cell Genet 70:188, 1995
15. Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, Stone R, Weissman SM, Hudson TJ, Fletcher JA: FGFRl is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaernia/lymphoma syndrome. Nat Genet 18:84, 1998
16. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM: The novel activation of ABLby fusion to an ets-related gene, TEL. Cancer Res 55:34, 1995
17. Beverloo HB, Le Coniat M, Wijsman J, Lillington DM, Bernard O, de Klein A, van Wering E, Welborn J, Young BD, Hagemeijer A, Berger R: Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis. Cancer Res 55:4220, 1995
18. Smedley D, Somers G, Venter D, Chung WC, Cooper C, Shipley J: Characterization of a t(8;13)(p11;q11-12) in an atypical myeloproliferative disorder. Genes Chromosomes Cancer 21:70, 1998
19. van der Maarel SM, Scholten IH, Huber I, Philippe C, Suijkerbuijk RF, Gilgenkrantz S, Kere J, Cremers FP, Ropers HH: Cloning and characterization of DXS6673E, a candidate gene for X-linked mental retardation in Xq13.1. Hum Mol Genet 5:887, 1996
20. Mackay JP, Crossley M: Zinc fingers are sticking together. Trends Biochem Sci 23:1, 1998
21. Mason U: The ins and outs of fibroblast growth factors. Cell 78:547, 1994
22. Kouhara H, Hadari YR, Spivak Kroizman T, Schilling J, Bar Sagi D, Lax I, Schlessinger J: A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89:693, 1997
23. Sakamoto H, Mon M, Taira M, Yoshida T, Matsukawa S, Shimizu K, Sekiguchi M, Terada M, Sugimura T: Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa, Proc Natl Acad Sci USA 83:3997, 1986
24. Peters G, Brookes S, Smith R, Placzek M, Dickson C: The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors. Proc Natl Acad Sci USA 86:5678, 1989
25. Lorenzi MV, Horii Y, Yamanaka R, Sakaguchi K, Miki T: FRAG1, a gene that potently activates fibroblast growth factor receptor by C-terminal fusion through chromosomal rearrangement. Proc Natl Acad Sci USA 93:8956, 1996
26. Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL: Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260, 1997
27. McWhirter JR, Galasso DL, Wang JY: A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol Cell Biol 13:7587, 1993
28. Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG: The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways. Proc Natl Acad Sci USA 93:14845, 1996
29. Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG: Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 16:4107, 1996
30. Crosstey M, Merika M, Qrkin SH: Self-association of the erythroid transcription factor GATA-1 mediated by its zinc finger domains. Mol Cell Biol 15:2448, 1995
31. De Valck D, Heyninck K, Van Criekinge W, Contreras R, Beyaert R, Fiers W: A20, an inhibitor of cell death, self-associates by its zinc finger domain. FEES Lett 384:61, 1996
32. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S, Winter RM: A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 8:269, 1994
33. Webster MK, Donoghue DJ: FGFR activation in skeletal disorders: Too much of a good thing. Trends Genet 13:178, 1997
34. Heisterkamp N, Stam K, Groffen J, de Klein A, Grosveld G: Structural organization of the bcr gene and its role in the Ph' translocation. Nature 315:758, 1985
35. Shtivelman E, Lifshitz B, Gale RP, Canaani E: Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315:550, 1985
36. Andreasson P, Johansson B, Carlsson M, Jarlsfelt I, Fioretos T, Mitelman F, Hoglund M: BCR/ABL negative chronic myeloid leukemia with ETV6/ABL fusion. Genes Chromosomes Cancer 20:299, 1997
37. Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H, Marynen P: Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 90:2535, 1997
38. Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307, 1994
39. Dionne CA, Crumley G, Bellot F, Kaplow JM, Searfoss G, Ruta M, Burgess WH, Jaye M, Schlessinger J: Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors, EMBO J 9:2685, 1990